Chr Hansen Holding A/S
CSE:CHR
Intrinsic Value
Chr.Hansen Holding A/S is a bioscience company engaged in the development of natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. [ Read More ]
The intrinsic value of one
CHR
stock under the Base Case scenario is
371.02
DKK.
Compared to the current market price of 549.6 DKK,
Chr Hansen Holding A/S
is
Overvalued by 32%.
CHR's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
CHR or that its price is influenced by factors unrelated to fundamentals.
Chr Hansen Holding A/S's market capitalization is 72.3B DKK.
CHR stock price is 549.6 DKK.
CHR stock (371.02 DKK) is 32% less than its price (549.6 DKK).
CHR stock (477.39 DKK) is 13% less than its price (549.6 DKK). Open Relative Valuation
CHR has downside potential of 5% compared to the average analyst price target.
Open Wall St Estimates
CHR's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 9%.
CHR's ROE (Return on Equity) for the past 12 months is positive and is equal to 12%.
CHR has positive three-year average ROIC (Return on Invested Capital): 11%. The company is efficient at using invested capital to generate operating income.
CHR's Revenue has grown by 10% over the past 12 months.
CHR's Revenue is forecast to grow at a rate of 6% per year over the next 3 years.
CHR's ROIC (Return on Invested Capital) has decreased in the last 3 years from 17% to 9%.
CHR's Revenue has been growing by 11% per year for the last 3 years.
CHR's short-term assets (521m EUR) exceed its short-term liabilties (362m EUR).
CHR earns more than enough operating income (358m EUR) to safely cover interest payments on its debt (31m EUR).
CHR has positive Operating Income for the last twelve months.
CHR's ROE (Return on Equity) has significantly decreased in the last 3 years from 46% to 12%.
CHR has positive Free Cash Flow for the last twelve months.
CHR has positive Net Income for the last twelve months.
CHR's long-term assets (3B EUR) exceed its long-term liabilties (2B EUR).
CHR's D/E (Debt to Equity) is very low and is equal to 0.49.
CHR has positive Gross Profit for the last twelve months.
CHR has very high three-year average ROE (Return on Equity): 38%. The company is very efficient at transforming stockholders' equity into net income.
CHR has positive Net Debt. This means that the company has more debt (923m EUR) than cash and short-term investments (56m EUR).
CHR's Altman Z-Score is very high and is equal to 24.68.
Valuation Backtest
Chr Hansen Holding A/S
Run backtest to discover the historical profit from buying and selling
CHR
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Chr Hansen Holding A/S
Balance Sheet Decomposition
Chr Hansen Holding A/S
| Current Assets | 521.2m |
| Cash & Short-Term Investments | 56m |
| Receivables | 256.2m |
| Other Current Assets | 209m |
| Non-Current Assets | 2.9B |
| Long-Term Investments | 3.6m |
| PP&E | 981.8m |
| Intangibles | 1.8B |
| Other Non-Current Assets | 90.8m |
| Current Liabilities | 362.3m |
| Accounts Payable | 111.5m |
| Other Current Liabilities | 250.8m |
| Non-Current Liabilities | 1.2B |
| Long-Term Debt | 923.4m |
| Other Non-Current Liabilities | 244.6m |
Earnings Waterfall
Chr Hansen Holding A/S
|
Revenue
|
1.3B
EUR
|
|
Cost of Revenue
|
-611.1m
EUR
|
|
Gross Profit
|
723.3m
EUR
|
|
Operating Expenses
|
-365m
EUR
|
|
Operating Income
|
358.3m
EUR
|
|
Other Expenses
|
-131.3m
EUR
|
|
Net Income
|
227m
EUR
|
Free Cash Flow Analysis
Chr Hansen Holding A/S
CHR Profitability Score
Profitability Due Diligence
Chr Hansen Holding A/S's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Chr Hansen Holding A/S's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
CHR Solvency Score
Solvency Due Diligence
Chr Hansen Holding A/S's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Score
Chr Hansen Holding A/S's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CHR Price Targets Summary
Chr Hansen Holding A/S
According to Wall Street analysts, the average 1-year price target for
CHR
is 520.3 DKK
.
Shareholder Return
CHR Price
Chr Hansen Holding A/S
| Average Annual Return | -5.35% |
| Standard Deviation of Annual Returns | 20.17% |
| Max Drawdown | -49% |
| Market Capitalization | 72.3B DKK |
| Shares Outstanding | 131 602 227 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Chr Hansen Holding A/S
Country
Industry
Market Cap
Dividend Yield
Description
Chr.Hansen Holding A/S is a bioscience company engaged in the development of natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. The Company’s business is divided into three divisions, namely Food Cultures & Enzymes, Health & Nutrition and Natural Colors. The Food Cultures & Enzymes division develops and produces cultures, enzymes and probiotics for the food industry in general and the dairy industry in particular. The Health & Nutrition division develops, produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula and animal feed industries. The Natural Colors division develops and supplies natural color solutions to the food and beverage industry, in particular the beverage, confectionery, ice cream, dairy, fruit preparation and prepared food segments. The firm operates in Europe, North and South America, as well as Asia Pacific, Middle East and Africa.
Contact
IPO
Employees
Officers
The intrinsic value of one
CHR
stock under the Base Case scenario is
371.02
DKK.
Compared to the current market price of 549.6 DKK,
Chr Hansen Holding A/S
is
Overvalued by 32%.
You don't have any saved screeners yet
